Several patients treated with IL-1 blocking agents have had improvement in their anemia but none have had repeat bone marrow biopsies to determine if the dyserythropoeisis which is a classic part of the disease is reversed with IL-1 blockade. The gene discussed is IL1A; the disease is anemia.